CERS - Cerus Corporation, a biomedical products company developing INTERCEPT Blood System. The INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion.

The company markets the INTERCEPT system for platelets and plasma primarily in Europe, the Russian Federation, and the Middle East. The company is also developing INTERCEPT Blood System for red blood cells or red blood cell system, which is designed to inactivate blood-borne pathogens in donated red blood cells for transfusion. Cerus Corporation has collaboration agreements with Baxter, BioOne Corporation and the United States Armed Forces. Very Attractive, keep an eye!

CBRX - Columbia Labs, is focused on development and commercialization of women’s healthcare and endocrinology products. It develops products by utilizing its bioadhesive drug delivery technologies.

The company offers bioadhesive vaginal gel products that provide solutions for infertility, pregnancy support, amenorrhea, gynecologic, and other medical conditions. Its products include CRINONE and PROCHIEVE, which are progesterone gels; and STRIANT, a testosterone buccal system. Bouncing back from 52WK LOWS.

You are missing the Premium Alerts!Sign-up, Get Alerts that MakeMoney!®

we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks